Travere Therapeutics (TVTX) Interest & Investment Income (2016 - 2025)
Historic Interest & Investment Income for Travere Therapeutics (TVTX) over the last 13 years, with Q3 2025 value amounting to $3.0 million.
- Travere Therapeutics' Interest & Investment Income fell 1464.99% to $3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.9 million, marking a year-over-year decrease of 3424.01%. This contributed to the annual value of $17.8 million for FY2024, which is 1815.05% down from last year.
- As of Q3 2025, Travere Therapeutics' Interest & Investment Income stood at $3.0 million, which was down 1464.99% from $3.3 million recorded in Q2 2025.
- Travere Therapeutics' Interest & Investment Income's 5-year high stood at $14.4 million during Q4 2022, with a 5-year trough of -$5.3 million in Q1 2021.
- Its 5-year average for Interest & Investment Income is $1.9 million, with a median of $3.6 million in 2024.
- Per our database at Business Quant, Travere Therapeutics' Interest & Investment Income soared by 41305.86% in 2022 and then plummeted by 5044.35% in 2023.
- Quarter analysis of 5 years shows Travere Therapeutics' Interest & Investment Income stood at -$4.6 million in 2021, then soared by 413.06% to $14.4 million in 2022, then crashed by 50.44% to $7.2 million in 2023, then tumbled by 46.94% to $3.8 million in 2024, then decreased by 19.71% to $3.0 million in 2025.
- Its Interest & Investment Income stands at $3.0 million for Q3 2025, versus $3.3 million for Q2 2025 and $3.8 million for Q1 2025.